vaccine novavax - Search News

News

FDA approves Moderna’s next-generation COVID-19 vaccine

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.

Rheumatology Advisor · 2d

FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Another Covid vaccine approval with restrictions attached

The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s existing Covid shot, Spikevax, does not currently face.

Zacks Investment Research on MSN7h

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

MedPage Today on MSN2dOpinion

An Uncertain Vaccines Market Keeps Getting Dicier

Unpredictable and politically driven regulatory approaches cultivate an environment of enormous uncertainty for vaccine ...

CNET on MSN5d

Will I Have to Pay for a COVID Vaccine and How Much Will It Cost?

Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.

5don MSN

Moderna’s new, lower-dose COVID-19 vaccine gets approved by the FDA

The FDA’s approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results